Oncogene - Table of Contents alert Volume 31 Issue 9

TABLE OF CONTENTS Volume 31, Issue 9 (March 2012) In this issue Original Articles Short Communications Oncogenomics Also new AOP Advertisement Family-based Analysis Webinar from Complete Genomics Listen to Dr. Rick Tearle, Complete Genomics Senior Field Application Specialist; discuss the advantages of using family-based analysis in whole genome sequencing studies to help identify causative variants of complex human disease. Analysis was performed using data derived from our 69 Genome Public Data Set, showing focused sets of accurate variants. View webinar here. Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Please take a look at this review that recently appeared in EMBO reports: Regulation and function of innate and adaptive interleukin-17-producing cells FREE Keiji Hirota, Helena Ahlfors, João H Duarte & Brigitta Stockinger EMBO reports | doi:10.1038/embor.2011.248   Original Articles Top P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance M A de la Cruz-Morcillo, M L L Valero, J L Callejas-Valera, L Arias-González, P Melgar-Rojas, E M Galán-Moya, E García-Gil, J García-Cano and R Sánchez-Prieto Oncogene 2012 31: 1073-1085; advance online publication, August 15, 2011; 10.1038/onc.2011.321 Abstract | Full Text Cdk-mediated phosphorylation of Chk1 is required for efficient activation and full checkpoint proficiency in response to DNA damage N Xu, S Libertini, E J Black, Y Lao, N Hegarat, M Walker and D A Gillespie Oncogene 2012 31: 1086-1094; advance online publication, July 18, 2011; 10.1038/onc.2011.310 Abstract | Full Text Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT C E de Andrea, C M A Reijnders, H M Kroon, D de Jong, P C W Hogendoorn, K Szuhai and J V M G Bovée Oncogene 2012 31: 1095-1104; advance online publication, August 1, 2011; 10.1038/onc.2011.311 Abstract | Full Text Synergistic growth inhibition based on small-molecule p53 activation as treatment for intraocular melanoma J de Lange, L V Ly, K Lodder, M Verlaan-de Vries, A F A S Teunisse, M J Jager and A G Jochemsen Oncogene 2012 31: 1105-1116; advance online publication, July 18, 2011; 10.1038/onc.2011.309 Abstract | Full Text ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence U Weyemi, O Lagente-Chevallier, M Boufraqech, F Prenois, F Courtin, B Caillou, M Talbot, M Dardalhon, A Al Ghuzlan, J-M Bidart, M Schlumberger and C Dupuy Oncogene 2012 31: 1117-1129; advance online publication, August 15, 2011; 10.1038/onc.2011.327 Abstract | Full Text Identification of stromally expressed molecules in the prostate by tag-profiling of cancer-associated fibroblasts, normal fibroblasts and fetal prostate B Orr, A C P Riddick, G D Stewart, R A Anderson, O E Franco, S W Hayward and A A Thomson Oncogene 2012 31: 1130-1142; advance online publication, August 1, 2011; 10.1038/onc.2011.312 Abstract | Full Text Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1 Y Liu, M W Mayo, A S Nagji, P W Smith, C S Ramsey, D Li and D R Jones Oncogene 2012 31: 1143-1154; advance online publication, July 18, 2011; 10.1038/onc.2011.308 Abstract | Full Text Absence of Wip1 partially rescues Atm deficiency phenotypes in mice Y Darlington, T-A Nguyen, S-H Moon, A Herron, P Rao, C Zhu, X Lu and L A Donehower Oncogene 2012 31: 1155-1165; advance online publication, July 18, 2011; 10.1038/onc.2011.303 Abstract | Full Text Defining a role for sphingosine kinase 1 in p53-dependent tumors L A Heffernan-Stroud, K L Helke, R W Jenkins, A-M De Costa, Y A Hannun and L M Obeid Oncogene 2012 31: 1166-1175; advance online publication, July 18, 2011; 10.1038/onc.2011.302 Abstract | Full Text Hipk2 cooperates with p53 to suppress γ-ray radiation-induced mouse thymic lymphoma J-H Mao, D Wu, I-J Kim, H C Kang, G Wei, J Climent, A Kumar, F G Pelorosso, R DelRosario, E J Huang and A Balmain Oncogene 2012 31: 1176-1180; advance online publication, July 25, 2011; 10.1038/onc.2011.306 Abstract | Full Text Short Communications Top DNA hypermethylation in lung cancer is targeted at differentiation-associated genes E Helman, K Naxerova and I S Kohane Oncogene 2012 31: 1181-1188; advance online publication, August 1, 2011; 10.1038/onc.2011.307 Abstract | Full Text Human homolog of Drosophila expanded, hEx, functions as a putative tumor suppressor in human cancer cell lines independently of the Hippo pathway S Visser-Grieve, Y Hao and X Yang Oncogene 2012 31: 1189-1195; advance online publication, July 25, 2011; 10.1038/onc.2011.318 Abstract | Full Text Oncogenomics Top A refined molecular taxonomy of breast cancer M Guedj, L Marisa, A de Reynies, B Orsetti, R Schiappa, F Bibeau, G MacGrogan, F Lerebours, P Finetti, M Longy, P Bertheau, F Bertrand, F Bonnet, A L Martin, J P Feugeas, I Bièche, J Lehmann-Che, R Lidereau, D Birnbaum, F Bertucci, H de Thé and C Theillet Oncogene 2012 31: 1196-1206; advance online publication, July 25, 2011; 10.1038/onc.2011.301 Abstract | Full Text Advertisement Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function. Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.